Revlon (REV) Downgraded to “Strong Sell” at Zacks Investment Research

Revlon (NYSE:REV) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a research note issued to investors on Wednesday.

According to Zacks, “Revlon, Inc. conducts its business exclusively through its subsidiary, Revlon Consumer Products Corp. and its subsidiaries. They manufacture, market and sell an extensive array of cosmetics and skin care, fragrances and personal care products. Their brand names are REVLON, COLORSTAY, REVLON AGE DEFYING, ALMAY and ULTIMA II in cosmetics; MOON DROPS, ETERNA 27, ULTIMA II and JEANNE GATINEAU in skin care; CHARLIE and FIRE & ICE in fragrances; and FLEX, OUTRAGEOUS, MITCHUM, COLORSTAY, COLORSILK, JEAN NATE, PLUSBELLE, BOZZANO and COLORAMA in personal care. “

REV has been the subject of a number of other reports. ValuEngine raised Revlon from a “sell” rating to a “hold” rating in a report on Saturday, June 2nd. Jefferies Financial Group reissued a “hold” rating and issued a $18.00 price target on shares of Revlon in a report on Friday, August 10th.



NYSE REV opened at $17.40 on Wednesday. Revlon has a fifty-two week low of $14.00 and a fifty-two week high of $27.90. The firm has a market capitalization of $921.88 million, a PE ratio of -9.02 and a beta of 0.28. The company has a quick ratio of 0.53, a current ratio of 1.01 and a debt-to-equity ratio of -2.70.

Revlon (NYSE:REV) last released its quarterly earnings results on Thursday, August 9th. The company reported ($1.54) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.27) by ($1.27). The firm had revenue of $606.80 million during the quarter, compared to the consensus estimate of $637.30 million. research analysts predict that Revlon will post -1.84 earnings per share for the current fiscal year.

In related news, Director Ronald O. Perelman purchased 75,000 shares of the business’s stock in a transaction dated Tuesday, August 14th. The stock was bought at an average cost of $17.30 per share, with a total value of $1,297,500.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Ronald O. Perelman bought 138,943 shares of the company’s stock in a transaction that occurred on Friday, August 10th. The stock was acquired at an average price of $16.34 per share, with a total value of $2,270,328.62. The disclosure for this purchase can be found here. Insiders own 85.00% of the company’s stock.

Institutional investors have recently added to or reduced their stakes in the stock. Allianz Asset Management GmbH increased its stake in Revlon by 104.7% in the first quarter. Allianz Asset Management GmbH now owns 13,464 shares of the company’s stock valued at $277,000 after purchasing an additional 300,000 shares during the last quarter. Schwab Charles Investment Management Inc. increased its stake in Revlon by 9.0% in the first quarter. Schwab Charles Investment Management Inc. now owns 63,315 shares of the company’s stock valued at $1,305,000 after purchasing an additional 5,240 shares during the last quarter. Deutsche Bank AG increased its stake in Revlon by 114.2% in the fourth quarter. Deutsche Bank AG now owns 26,367 shares of the company’s stock valued at $574,000 after purchasing an additional 14,059 shares during the last quarter. OZ Management LP acquired a new position in Revlon in the first quarter valued at $1,378,000. Finally, MetLife Investment Advisors LLC acquired a new position in Revlon in the fourth quarter valued at $130,000. Hedge funds and other institutional investors own 14.64% of the company’s stock.

About Revlon

Revlon, Inc, through its subsidiaries, manufactures, markets, distributes, and sells beauty and personal care products worldwide. The company's Consumer segment offers cosmetics under the Revlon, Almay, SinfulColors, and Pure Ice brands; women's hair color products under the Revlon ColorSilk brand; beauty tools under the Revlon brand; nail care products under the Cutex brand; and anti-perspirant deodorants under the Mitchum name, as well as skin care line under the Natural Honey brand and hair color line under the Llongueras brand.

See Also: Trading Strategy

Get a free copy of the Zacks research report on Revlon (REV)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Revlon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revlon and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply